Thermo Fisher Scientific, Inc.

Stocks

TMO

US8835561023

Market Closed - NYSE Other stock markets 21:00:02 17/07/2026 BST			5-day change	1st Jan Change
532.48 ^USD	-1.97%		+1.03%	-8.11%

07-16	Devyser launches updated test for chimerism analysis	FW
07-13	OmniAb Appoints Amechi Nwachuku as Chief Operating Officer	MT

Transcript : Thermo Fisher Scientific Inc. - Analyst/Investor Day

Published on 05/20/2026 at 05:20 pm BST - Modified on 05/22/2026 at 10:03 pm BST

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Welcome to Thermo Fisher Scientific's Investor Day Meeting. And now Vice President of Investor Relations Rafael Tejada.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Thermo Fisher Scientific, Inc.

07-16	Devyser launches updated test for chimerism analysis	FW
07-13	OmniAb Appoints Amechi Nwachuku as Chief Operating Officer	MT
07-13	Baird Adjusts Price Target on Thermo Fisher Scientific to $652 From $639, Maintains Outperform Rating	MT
07-09	Thermo Fisher Scientific Keeps Quarterly Dividend at $0.47 per Share, Payable Oct. 15 to Holders of Record Sept. 15	MT
07-09	Thermo Fisher Scientific Inc. Announces Quarterly Dividend, Payable on October 15, 2026	CI
07-07	Thermo Fisher Scientific Receives FBI Approval for Applied Biosystems RapidINTEL Plus Cartridge Enabling Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches	CI
07-06	Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $570 From $575	MT
07-06	Evercore ISI Adjusts Thermo Fisher Scientific Price Target to $204 From $205	MT
07-02	Arcturus Therapeutics Holdings Inc. And Thermo Fisher Scientific Inc. Announce Strategic Collaboration To Advance ARCT-032 For Cystic Fibrosis	CI
07-02	Arcturus Therapeutics Shares Rise on Plans to Work with Thermo Fisher Scientific on Cystic Fibrosis Drug	DJ
07-02	Arcturus Therapeutics, Thermo Fisher Scientific to Collaborate on Advancing ARCT-032 in Cystic Fibrosis	MT
06-30	Austinpx and Thermo Fisher Scientific Enter Agreement for Installation of Kinetisol Technology Equipment	CI
06-29	Genedrive plc And Thermo Fisher Scientific Inc Enters Collaboration Agreement For CYP2C19 Product Development	CI
06-29	Secure Trust starts buyback; Smiths News contract win	AN
06-29	Genedrive Teams Up with Thermo Fisher Scientific to Develop Laboratory-based Genetic Test	MT